GlaxoSmithKline Pharmaceuticals Ltd
NSE:GLAXO

Watchlist Manager
GlaxoSmithKline Pharmaceuticals Ltd Logo
GlaxoSmithKline Pharmaceuticals Ltd
NSE:GLAXO
Watchlist
Price: 2 859.8999 INR -1.61%
Market Cap: 484.5B INR

Intrinsic Value

The intrinsic value of one GLAXO stock under the Base Case scenario is 1 283.4152 INR. Compared to the current market price of 2 859.8999 INR, GlaxoSmithKline Pharmaceuticals Ltd is Overvalued by 55%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GLAXO Intrinsic Value
1 283.4152 INR
Overvaluation 55%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
GlaxoSmithKline Pharmaceuticals Ltd

GLAXO
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for GLAXO cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

GlaxoSmithKline Pharmaceuticals Ltd
NSE:GLAXO
IN
Pharmaceuticals
Market Cap
484.5B INR
IPO
Nov 3, 1994
IN
Pharmaceuticals
Market Cap
484.5B INR
IPO
Nov 3, 1994
Price
₹false
EPS
₹false
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about GLAXO?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about GlaxoSmithKline Pharmaceuticals Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
GlaxoSmithKline Pharmaceuticals Ltd

Current Assets 30.1B
Cash & Short-Term Investments 21.9B
Receivables 2.7B
Other Current Assets 5.6B
Non-Current Assets 7.3B
Long-Term Investments 118.5m
PP&E 3B
Intangibles 183.4m
Other Non-Current Assets 4B
Efficiency

Free Cash Flow Analysis
GlaxoSmithKline Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
GlaxoSmithKline Pharmaceuticals Ltd

Revenue
37B INR
Cost of Revenue
-14.1B INR
Gross Profit
23B INR
Operating Expenses
-12.7B INR
Operating Income
10.3B INR
Other Expenses
-1.7B INR
Net Income
8.6B INR
Fundamental Scores

GLAXO Profitability Score
Profitability Due Diligence

GlaxoSmithKline Pharmaceuticals Ltd's profitability score is 81/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional 3-Year Average ROIC
Positive Gross Profit
Positive Free Cash Flow
81/100
Profitability
Score

GlaxoSmithKline Pharmaceuticals Ltd's profitability score is 81/100. The higher the profitability score, the more profitable the company is.

GLAXO Solvency Score
Solvency Due Diligence

GlaxoSmithKline Pharmaceuticals Ltd's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Low D/E
Long-Term Solvency
77/100
Solvency
Score

GlaxoSmithKline Pharmaceuticals Ltd's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GLAXO Price Targets Summary
GlaxoSmithKline Pharmaceuticals Ltd

Wall Street analysts forecast GLAXO stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GLAXO is 2 670.105 INR with a low forecast of 2 191.7 INR and a high forecast of 3 412.5 INR.

Lowest
Price Target
2 191.7 INR
23% Downside
Average
Price Target
2 670.105 INR
7% Downside
Highest
Price Target
3 412.5 INR
19% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for GLAXO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

GLAXO Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one GLAXO stock?

The intrinsic value of one GLAXO stock under the Base Case scenario is 1 283.4152 INR.

Is GLAXO stock undervalued or overvalued?

Compared to the current market price of 2 859.8999 INR, GlaxoSmithKline Pharmaceuticals Ltd is Overvalued by 55%.

Back to Top